US$ 20.98
glp 1 gip dual agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica The dual agonist action of
Description
and global prevalence of type 2 diabetes and obesity, advancements in drug development, and expanding indications for weight loss and cardiovascular health
doi: 10.1042/BSR20160437 85 ZhangHMengJZhouSLiuYQuDWangLet al

Here, we discuss results from Wave 12, conducted in February 2025
2016;310(9):E77481

Lately, attention has been directed to GIP and its role in glucose homeostasis, and efforts are underway to develop compounds that mimic GIP actions in addition to those of GLP-1
obesity rates in over a decade 1
